Skip to main content

Govt Panel Says No to Serum Institute’s Covovax Trial on Children Aged 2-17 Years

New Delhi: Days after the Serum Institute of India (SII) authorities applied for permission from the Drug Controller and General of India (DCGI) to conduct a clinical trial of the Covovax vaccine among paediatric population, an expert panel recommended against it. The SII had sought permission to conduct the phase 2/3 trial of the Indian version of US-based Novavax Inc-developed vaccine named Covovax on children aged two to 17 years, sources said. The SII wanted to conduct the trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups, at 10 sites.

“The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO), which deliberated on the application, noted that the vaccine has not been approved in any country,” a source said.

“It also recommended that the Pune-based company should submit the safety and immunogenicity data (of Covovax) from the ongoing clinical trial in adults for considering the conduct of a clinical trial in children,” the source said.

The recommendations are learnt to have been approved by the DCGI. In August 2020, US-based vaccine maker Novavax Inc. had announced a licence agreement with the SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.

The clinical trials of Covovax began in India in March and the SII hopes to launch it by September for adults. In January, the SII had rolled out the Covishield vaccine in the country. It had entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.

(With Agency inputs)



source https://www.india.com/news/india/govt-panel-says-no-to-serum-institutes-covovax-trial-on-children-aged-2-17-years-4780293/

Comments

Popular posts from this blog

UK Makes Face Mask Mandatory As Omicron Virus Spreads, 22 Test Positive

London: Face coverings are mandatory in shops and public transport from Tuesday as part of targeted measures” to slow the spread of the Omicron variant, 22 cases of which have now been detected in the UK after Scotland and England reported further infections. Individuals linked with all new cases, identified in the East Midlands, the East of England, London, and the North West, are all isolating and the UK Health Security Agency (UKHSA) said work is underway to identify any links to travel to southern Africa. “It is very likely that we will find more cases over the coming days as we are seeing in other countries globally and as we increase case detection through focused contact tracing, said Dr Jenny Harries, UKHSA Chief Executive. The enhanced measures, announced last week as a precaution while more information is gathered and assessed on the new variant’s transmissibility and any possible effect on current COVID-19 vaccines, also include compulsory PCR tests on arrival for all int...

Weekly RT-PCR Mandatory For Unvaccinated Employees In Kerala. Details Here

Thiruvananthapuram : In an effort to make everyone get vaccinated, Kerala Chief Minister Pinarayi Vijayan on Tuesday said anyone not following COVID prevention measures, like vaccination, will not be provided free treatment. He also said that non-vaccinated teachers and employees who work from offices or interact with public will have to submit weekly results of RT-PCR tests. “No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RT-PCR tests, paid for by themselves, to ensure safety of all,” Vijayan said in a tweet. No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RTPCR tests, paid for by themselves, to ensure safety of all. — Pinarayi Vijayan (@vijayanpinarayi) November ...